Reference
Cherla A, et al. Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England. EClinicalMedicine : 5 Nov 2020. Available from: URL: https://doi.org/10.1016/j.eclinm.2020.100625
Rights and permissions
About this article
Cite this article
Decisions by ICER and NICE discordant for some cancer drugs. PharmacoEcon Outcomes News 866, 10 (2020). https://doi.org/10.1007/s40274-020-7270-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7270-y